M42’s IROS partners with Halia Therapeutics to launch clinical study on obesity treatment in UAE
UAE—IROS, an Abu Dhabi-based contract research organization has partnered with Halia Therapeutics,...
Read MoreSelect Page
Jan 8, 2025
UAE—IROS, an Abu Dhabi-based contract research organization has partnered with Halia Therapeutics,...
Read MoreNov 22, 2024
UAE—M42, a global leader in healthcare technology and the largest healthcare provider in the...
Read MoreOct 30, 2024
UAE—M42, a tech-driven leader in global healthcare innovation, has appointed Paul Jones as the...
Read MoreOct 25, 2024
UAE—Healthpoint, a prominent member of the M42 group, has introduced innovative vascular care...
Read MoreOct 25, 2024
UAE— Danat Al Emarat Hospital for Women & Children, part of M42, has announced that the Royal...
Read MoreOct 22, 2024
UAE— M42’s Danat Al Emarat Hospital for Women & Children, a leading specialty hospital in Abu...
Read MoreOct 16, 2024
UAE – M42’s Capital Health Screening Centre (CHSC), a leading facility for visa screenings, has...
Read MoreOct 9, 2024
UAE —Abu Dhabi’s Healthpoint, a multi-specialty hospital under the M42 group, has expanded its...
Read MoreOct 4, 2024
UAE – M42, a global health-tech leader, has signed a Memorandum of Understanding (MoU) with ADGM...
Read MoreSep 27, 2024
UAE — The Danat Al Emarat Hospital for Women & Children, part of the M42 group, has opened a...
Read More